Cookie Img
Back to top
   Call Me Free Offline Send SMSSend SMS Send InquirySend Inquiry
Home » Products » Everolimus » Everolimus

Everolimus

Everolimus
Everolimus
Product Code : Everolimus
Brand Name : Glenmark Everolimus
Product Specifications
  • Drug Type
  • Health Supplements
  • Ingredients
  • Everolimus
  • Physical Form
  • Tablets
  • Function
  • Anti-Cancer
  • Dosage
  • 10 mg
  • Suitable For
  • Suitable For All
Product Description

Details

  •  Brand Name - Evermil
  • Generic - Everolimus
  • Strength - 10 Mg
  • Form - Tablets
  • Packing - 1 X 10
  • Manufactured - Glenmark pharmceuticals 
Evermil tablets contain the active ingredient everolimus, which is a type of medicine known as a protein kinase inhibitor. It works by interfering with the pathways that signal certain cancer cells to grow.

Disclaimer: The information provided above is general. It does not inculde all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. It is not intended as medical advice, and should not be relied upon as a subititute for your doctor's advivce. Please consult your docotor / medical practitioner / health consult / nurse / hospital / health care adviser before taking any action towards your medical condition.

Trade Information
  • Payment Terms
  • Cash on Delivery (COD), Telegraphic Transfer (T/T), Western Union, Others
  • Main Export Market(s)
  • Asia, Australia, Central America, North America, South America, Eastern Europe, Western Europe, Middle East, Africa
  • Main Domestic Market
  • All India

HEPATITIS C DRUGS SUPPLIERS

Contact Us

( *represents compulsory fields )

Tips on getting accurate quotes. Please include product name, order quantity, usage, special requests if any in your inquiry.



HEPATITIS C DRUGS SUPPLIERS
Shop No. G- 7/31, Ansari Road, Darya Ganj, Delhi - 110002, India
Phone :+919206046354
Mr. Kamal Jindal (Proprietor)
Mobile :+919206046354
Trust Stamp
Product Showcase
   Call Me Free Offline Send SMSSend SMS Send InquirySend Inquiry